مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| امتیاز ولز برای ترومبوز ورید عمقی (DVT)× | امتیاز CHA₂DS₂-VASc× | |
|---|---|---|
| حوزه | ارزیابی بالینی | ارزیابی بالینی |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 1994 | 2010 |
| پدیدآور≠ | Philip S. Wells | Gregory Y. H. Lip, Robby Nieuwlaat, et al. |
| نوع≠ | Venous thromboembolism risk stratification | Atrial fibrillation stroke risk stratification |
| منبع بنیادین≠ | Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546. link ↗ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ |
| نامهای دیگر | Wells DVT Score, DVT Wells | CHA2DS2VASc, Atrial fibrillation stroke risk |
| مرتبط | 3 | 3 |
| خلاصه≠ | The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients. | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. |
| ScholarGateمجموعهداده ↗ |
|
|